Technische Universität München (TUM)

University / College


Location: München, Germany (DE) DE

ISNI: 0000000123222966

ROR: https://ror.org/02kkvpp62

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Changes of omentin-1 and chemerin during 4 weeks of lifestyle intervention and 1 year follow-up in children with obesity (2021) Siegrist M, Heitkamp M, Braun I, Vogg N, Haller B, Langhof H, Koenig W, Halle M Journal article Informed Employees - Informed Consent as Ethical Guidance for Behavioural Prevention in the Corporate Context Aufgeklärte Mitarbeiter/innen - Die informierte Einwilligung als ethische Orientierung für Verhaltensprävention im betrieblichen Kontext (2021) Kuhn E, Mueller S, Heidbrink L, Buyx A Journal article Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists (2021) Vogel MME, Dewes S, Sage EK, Devecka M, Gschwend JE, Schiller K, Combs SE Journal article MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy (2021) Peeken JC, Asadpour R, Specht K, Chen EY, Klymenko O, Akinkuoroye V, Hippe DS, et al. Journal article Histopathological tumor and normal tissue responses after 3d-planned arc radiotherapy in an orthotopic xenograft mouse model of human pancreatic cancer (2021) Dobiasch S, Kampfer S, Steiger K, Schilling D, Fischer JC, Schmid TE, Weichert W, et al. Journal article A comprehensive prospective comparison of acute skin toxicity after hypofractionated and normofractionated radiation therapy in breast cancer (2021) Borm KJ, Kleine Vennekate J, Vagedes J, Islam MOA, Duma MN, Loos M, Combs SE, et al. Journal article Efficacy of Internet-Based Treatment for Genito-Pelvic Pain/Penetration Disorder: Results of a Randomized Controlled Trial (2021) Zarski AC, Berking M, Ebert DD Journal article Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF(V600) mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial (2021) Zimmer L, Livingstone E, Krackhardt A, Schultz ES, Goppner D, Assaf C, Trebing D, et al. Journal article Towards cross-commodity energy-sharing communities – A review of the market, regulatory, and technical situation (2021) Paiho S, Kiljander J, Sarala R, Siikavirta H, Kilkki O, Bajpai A, Duchon M, et al. Journal article, Review article COVID-19 vs. stakeholder engagement: the impact of coronavirus containment measures on stakeholder involvement in European energy research projects (2021) Süsser D, Ceglarz A, Stavrakas V, Lilliestam J Journal article